A phase 1b dose optimization study of sovilnesib (an oral KIF18A inhibitor) in subjects with advanced high grade serous ovarian cancer
ENROLLING
Trial ID:
NCT06084416 Protocol # :
23-702
Phase
I
Disease Sites
Corpus Uteri
Ovary
Other Female Genital
Principal Investigator
Liu, Joyce, F
Site Research Nurses
Belavusava, Vera
Doherty, Kelsie
Hindenach, Sarah
McNamara, Taylor
Morrissey, Stephanie, C.
Neals, Allison
Trial Description
Call 877-DF-TRIAL (877-338-7425) to learn more about this clinical trial, protocol #23-702
23-702